Transplant in Ph+ Acute Lymphoblastic Leukemia: When, Why, and How?
Transplant in Ph+ Acute Lymphoblastic Leukemia: When, Why, and How?
Track: BMT Tandem "Scientific" Meeting
Thursday, February 27, 2014, 12:30 PM-1:30 PM
Texas B+D (Gaylord Texan)
Disclosures:
J. M. Rowe,
Sanofi-Aventis, Amgen: Consulting Fees